Plain-English translation of NCT06085144 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Migraine research guide →Researchers want to understand how much of the migraine medication passes into breast milk when nursing mothers take it after delivery. This information will help doctors make safer decisions about whether nursing mothers with migraines can continue or start this treatment while breastfeeding. Right now, there isn't enough research on this specific question.
Many nursing mothers with migraines need treatment to feel better, but doctors worry about whether this medication is safe for babies through breast milk. This study fills that gap by measuring actual levels of the medication in milk, so doctors can give better advice to breastfeeding mothers.
You likely qualify if…
You likely don't qualify if…
You'll pump breast milk at specific times over 2-3 months—before your first dose and then at 1 day, 1 week, and 4 weeks after each treatment. You'll provide up to 8 small milk samples (about 1 tablespoon each), which you'll ship frozen to the research lab. You'll also fill out questionnaires about your baby's health at 6 months and 12 months after delivery, and the team will review your baby's medical records during that first year.
AI-generated summary from trial data · Jun 4, 2026 · Not medical advice
United States